Pregnancy is a delicate journey. Western medicine has evolved to provide the best possible care for pregnant moms – in hospitals and in clinics. But what happens during and after a missile attack when the facilities are not safe or accessible? What happens when pregnant moms who were already hospitalized for high-risk conditions such as preeclampsia or FGR, are suddenly told they must go home now because the hospital is under threat from missile attacks?
The answer sounds simple but was over a decade in the making: if you cannot bring the pregnant mom to the hospital, bring the hospital to the pregnant mom!
In Israel this was fast-tracked into reality after Oct 7. What has happened since and especially now during the current Israel crisis, is transforming pregnancy care with global implications that extend well beyond Israel’s present crisis.
Stage 1: Oct 8, 2023 – Moving Mountains, Cutting Through Bureaucracy
In the days following the horrific events of Oct 7, 2023 the urgency of the moment cut through the typical layers of healthcare bureaucracy. Sheba Beyond Maternity Care, a leading clinic in Israel, was ordered to clear out the maternity ward to make space in the hospital for the anticipated dramatic increase in soldier and civilian casualties. However, sending high-risk pregnant moms home without proper care could dramatically increase the risk of an adverse, and possibly life-threatening, outcome.
As fate would have it, Sheba Beyond was already collaborating in a clinical study with Nuvo, an innovative Israeli start-up that pioneered a groundbreaking wearable platform called INVU that was specifically designed to enable moms to monitor themselves and their baby-in-utero from anywhere, anytime, with medical data automatically sent to their physicians. The perfect solution in a time of need – as long as INVU could be approved by the Israel Health Ministry. Nuvo had good reason to be concerned about timing since it had just previously received FDA approval only after years of regulatory review.
This time it took just three weeks! The Israel Health Ministry fast-tracked the approval for the use of INVU to de-hospitalize high-risk patients based on the results of the already in progress clinical study being conducted by Sheba Beyond and Nuvo, along with the extensive clinical evidence that was used to receive the U.S. FDA approval.
Sheba Beyond has been de-hospitalizing high-risk pregnancies ever since and monitoring them remotely using INVU with exceptional results. Moms with high-risk pregnancies who would otherwise be confined to a hospital ward are instead receiving care from the comfort of their home or work with full medical oversight. The positive outcomes of Sheba Beyond’s experience has become the basis of significant ongoing studies, with initial results published in a major medical peer reviewed journal as well as presented at a prominent medical conference.
Read more...
The answer sounds simple but was over a decade in the making: if you cannot bring the pregnant mom to the hospital, bring the hospital to the pregnant mom!
In Israel this was fast-tracked into reality after Oct 7. What has happened since and especially now during the current Israel crisis, is transforming pregnancy care with global implications that extend well beyond Israel’s present crisis.
Stage 1: Oct 8, 2023 – Moving Mountains, Cutting Through Bureaucracy
In the days following the horrific events of Oct 7, 2023 the urgency of the moment cut through the typical layers of healthcare bureaucracy. Sheba Beyond Maternity Care, a leading clinic in Israel, was ordered to clear out the maternity ward to make space in the hospital for the anticipated dramatic increase in soldier and civilian casualties. However, sending high-risk pregnant moms home without proper care could dramatically increase the risk of an adverse, and possibly life-threatening, outcome.
As fate would have it, Sheba Beyond was already collaborating in a clinical study with Nuvo, an innovative Israeli start-up that pioneered a groundbreaking wearable platform called INVU that was specifically designed to enable moms to monitor themselves and their baby-in-utero from anywhere, anytime, with medical data automatically sent to their physicians. The perfect solution in a time of need – as long as INVU could be approved by the Israel Health Ministry. Nuvo had good reason to be concerned about timing since it had just previously received FDA approval only after years of regulatory review.
This time it took just three weeks! The Israel Health Ministry fast-tracked the approval for the use of INVU to de-hospitalize high-risk patients based on the results of the already in progress clinical study being conducted by Sheba Beyond and Nuvo, along with the extensive clinical evidence that was used to receive the U.S. FDA approval.
Sheba Beyond has been de-hospitalizing high-risk pregnancies ever since and monitoring them remotely using INVU with exceptional results. Moms with high-risk pregnancies who would otherwise be confined to a hospital ward are instead receiving care from the comfort of their home or work with full medical oversight. The positive outcomes of Sheba Beyond’s experience has become the basis of significant ongoing studies, with initial results published in a major medical peer reviewed journal as well as presented at a prominent medical conference.
Read more...